Fully Endoscopic Vascular Decompression of the Facial Nerve for Hemifacial Spasm

Eby, Joseph B.; Tae, Sung; Shahinian, Hrayr K.

doi:10.1055/s-2001-16607

Cited by 41 publications

(34 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Long-term follow-up studies show HFS recurrence rates ranging from 1 to 13% (5,7,12,15). When evaluating results for EVD in HFS patients, there are no studies to date reporting success rates, only isolated case reports (9).…”

Section: Discussionmentioning

confidence: 98%

Endoscopic Vascular Decompression

Artz

Hux²,

LaRouere³

et al. 2008

Otology &Amp; Neurotology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 98%

Endoscopic Vascular Decompression

Artz

Hux²,

LaRouere³

et al. 2008

Otology &Amp; Neurotology

View full text Add to dashboard Cite

show abstract

“…First described in 2001 by Eby et al, 6 E-MVD has now been reported in several single-center series. 2,7,11,21,24 All report excellent safety and short-to medium-term functional results.…”

Section: Discussionmentioning

confidence: 99%

Fully endoscopic microvascular decompression for trigeminal neuralgia: technique review and early outcomes

Bohman

Pierce²,

Stephen³

et al. 2014

FOC

View full text Add to dashboard Cite

Object Fully endoscopicmicrovascular decompression (E-MVD) of the trigeminal nerve was initially described more than 1 decade ago, but has not yet gained wide acceptance. The authors present the experience of their first 47 consecutive E-MVDs for trigeminal neuralgia (TN). Methods All surgeries were performed by a single surgeon (J.Y.K.L.) at the Pennsylvania Hospital at the University of Pennsylvania. Patients prospectively completed pain scales before and after surgery by using the Brief Pain Inventory–Facial outcomes tool. All patients were called on the telephone, and the same outcome tool was administered without reference to their preoperative pain status. Results Forty-seven patients (17 men) were identified and enrolled. Forty (85%) had Burchiel Type 1 TN. Vascular compression was observed at surgery in 42 patients (89%). No surgery was aborted or converted to microscope. One patient suffered permanent hearing loss, for a permanent neurological morbidity rate of 2%. Overall improvement in pain outcomes was excellent, with a median maximum pain intensity preoperatively of 10 and postoperatively of 0 (p< 0.0001). The mean interference with global function scores were 6.2 preoperatively and reduced to 1.0 at last follow-up (p < 0.0001). The mean interference with facial function was 7.3 preoperatively and reduced to 1.2 at last follow-up (p < 0.0001). The mean follow-up period after surgery was 15 ± 8 months. Conclusions In experienced hands, E-MVD offers superb visualization and illumination and is both safe and effective, at least in the short term. Further longer-term study is needed to compare E-MVD to traditional microscopic MVD.

show abstract

“…In 1994, Magnan et al [46] introduced a combined microscopic and endoscopic approach to vascular decompression which reduced the morbidity and increased the success rate of surgery. Eby et al [47] demonstrated the results of first cases of fully endoscopic vascular decompression and commented that this method is safer and more effective, providing better visualization. In the unsuccessful MVD cases, a recent report [48 ] suggests repeating the surgery, showing 100% effectiveness of second surgery in 13 cases of persistent/recurrent HFS.…”

Section: Treatment Of Hemifacial Spasmmentioning

confidence: 97%